p21 is a transcriptional target of HOXA10 in differentiating myelomonocytic cells
Open Access
- 15 October 2000
- journal article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 14 (20) , 2581-2586
- https://doi.org/10.1101/gad.817100
Abstract
The myeolomonocytic cell line U937 differentiates into macrophages in response to a variety of agents. Several genes including the cyclin-dependent kinase inhibitor p21waf1/cip1 and the homeobox gene transcription factor HOXA10 are induced at the onset of differentiation. Ectopic expression of either gene results in U937 differentiation. In this paper, we describe a mechanism by which p21 and HOXA10 may act in concert, where HOXA10 can bind directly to the p21 promoter and, together with its trimeric partners PBX1 and MEIS1, activate p21 transcription, resulting in cell cycle arrest and differentiation. These experiments for the first time identify p21 as a selective target for a HOX protein and link the differentiative properties of a transcription factor and a cell cycle inhibitor.Keywords
This publication has 34 references indexed in Scilit:
- Hematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1Science, 2000
- Enforced expression of HOXB7 promotes hematopoietic stem cell proliferation and myeloid-restricted progenitor differentiationOncogene, 1999
- Structure of a HoxB1–Pbx1 Heterodimer Bound to DNACell, 1999
- PKNOX1, a Gene Encoding PREP1, a New Regulator of Pbx Activity, Maps on Human Chromosome 21q22.3 and Murine Chromosome 17B/CGenomics, 1998
- New functional activities for the p21 family of CDK inhibitors.Genes & Development, 1997
- Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.Genes & Development, 1996
- Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1Nature, 1995
- The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNANature, 1994
- The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993